药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sulfadoxine
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Pomalidomide.
Sulfadoxine
Rotigotine
Pomalidomide may increase the sedative activities of Rotigotine.
Sulfadoxine
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Pomalidomide.
Sulfadoxine
Paraldehyde
Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Sulfadoxine
Methotrimeprazine
Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Sulfadoxine
Furafylline
The serum concentration of Pomalidomide can be increased when it is combined with Furafylline.
Sulfadoxine
Clinafloxacin
The serum concentration of Pomalidomide can be increased when it is combined with Clinafloxacin.
Sulfadoxine
Midostaurin
The serum concentration of Pomalidomide can be increased when it is combined with Midostaurin.
Sulfadoxine
Technetium Tc-99m ciprofloxacin
The serum concentration of Pomalidomide can be increased when it is combined with Technetium Tc-99m ciprofloxacin.
Sulfadoxine
Deferasirox
The serum concentration of Pomalidomide can be increased when it is combined with Deferasirox.
Sulfadoxine
Armodafinil
The metabolism of Pomalidomide can be increased when combined with Armodafinil.
Sulfadoxine
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Pomalidomide.
Sulfadoxine
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Pomalidomide.
Sulfadoxine
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Pomalidomide.
Sulfadoxine
Roflumilast
Roflumilast may increase the immunosuppressive activities of Pomalidomide.
Sulfadoxine
Siponimod
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Siponimod.
Sulfadoxine
Ibrutinib
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Ibrutinib.
Sulfadoxine
Bleselumab
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Bleselumab.
Sulfadoxine
Rozanolixizumab
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Rozanolixizumab.
Sulfadoxine
Risankizumab
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Risankizumab.